January 2015


Photo from Thinkstock

From too little to too much

Experts struggle to find the optimal venous thromboembolism prophylaxis strategy.

Infectious Disease | FREE
Most ACP Hospitalist and ACP Hospitalist Weekly content is available exclusively to ACP Members. This article is free to the public.

When it could be Ebola . . .

There are lots of differential diagnoses, too.

Conference Coverage | FREE
Most ACP Hospitalist and ACP Hospitalist Weekly content is available exclusively to ACP Members. This article is free to the public.

The current and future state of stroke treatment

Insight from UCSF's Management of the Hospitalized Patient conference.

Common curbside consults in infectious disease

Most popular questions revealed at UCSF conference.

SGLT2 inhibitors change the dynamic of glucose and the kidneys

Kidney Week session discusses new class of diabetes drugs.

Cases from Baystate Medical Center

Chlorpromazine-induced hepatitis, the Brugada pattern, persistent breast erythema, and more.

Searching for swift, secure communication

Pilot project shows use of the app is contagious among general medicine team members.

Encephalopathy

Clinicians often struggle with the distinction between delirium and encephalopathy.

Newman's Notions | FREE
Most ACP Hospitalist and ACP Hospitalist Weekly content is available exclusively to ACP Members. This article is free to the public.

The case of the undulant ungulate

A graduate student discovers the dangers of gourmet roadkill.

Improving teamwork through the selection of medical trainees

Admissions requirements and interviews could be modified to emphasize teamwork, among other strategies.

Letter from the Editor

This month's issue includes articles on the optimal use of prophylaxis for venous thromboembolism, differential diagnoses for Ebola, and conference coverage.

Recent Research

Scoring systems for pleural effusions, NSAIDS and VTE risk, and more.

In The News

Mixing alcohol with opioids and benzodiazepines, postdischarge efforts and readmissions, and more.